Maynard Um
-
-
-
-
-
-
-
Tenaya Therapeutics partners with Alnylam for heart disease targets
-
-
-
-
-
-
-
Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 4c
-
-
-
-
-
-
-
Tenaya Therapeutics Inc (TNYA) PT Lowered to $6 at Canaccord Genuity
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)
-
-
-
-
-
-
-
William Blair Starts Tenaya Therapeutics Inc (TNYA) at Outperform
416,229 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

